| Company Name: |
Amatek Scientific Co. Ltd.
|
| Tel: |
0512-56316828 |
| Email: |
info@amateksci.com |
| Products Intro: |
Product Name:THP-PEG9-OH
CAS:669556-83-6
Purity:97% HPLC Package:1g;5g;25g;100g
|
| Company Name: |
Xi'an Confluore Biological Technology Co., Ltd.
|
| Tel: |
+86-156-80926068 +86-15680926068 |
| Email: |
1924344760@qq.com |
| Products Intro: |
Product Name:OH-PEG9-THP
CAS:669556-83-6
Purity:98% HPLC Package:10MG;25MG;50MG;100MG;1G;5G Remarks:For customers outside China,please use the website:www.confluore.com
|
| Company Name: |
Beijing Jin Ming Biotechnology Co., Ltd.
|
| Tel: |
010-60605840 15801484223; |
| Email: |
psaitong@jm-bio.com |
| Products Intro: |
Product Name:THP-PEG9-OH
CAS:669556-83-6
Package:100mg;250mg;500mg Remarks: 试剂级
|
THP-PEG9-OH manufacturers
- OH-PEG9-THP
-
- $0.00 / 1g
-
2024-03-25
- CAS:669556-83-6
- Min. Order: 1g
- Purity: >98.00%
- Supply Ability: 1g
|
| | THP-PEG9-OH Basic information |
| Product Name: | THP-PEG9-OH | | Synonyms: | THP-PEG9-OH;OH-PEG9-THP;THP-PEG9-OH/3,6,9,12,15,18,21,24-Octaoxahexacosan-1-ol, 26-[(tetrahydro-2H-pyran-2-yl)oxy]-;3,6,9,12,15,18,21,24-Octaoxahexacosan-1-ol, 26-[(tetrahydro-2H-pyran-2-yl)oxy]- | | CAS: | 669556-83-6 | | MF: | C23H46O11 | | MW: | 498.6 | | EINECS: | | | Product Categories: | | | Mol File: | 669556-83-6.mol |  |
| | THP-PEG9-OH Chemical Properties |
| Boiling point | 569.2±50.0 °C(Predicted) | | density | 1.11±0.1 g/cm3(Predicted) | | pka | 14.36±0.10(Predicted) |
| | THP-PEG9-OH Usage And Synthesis |
| Uses | THP-PEG9-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | Biological Activity | THP-PEG9-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | | IC 50 | PEGs | | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| | THP-PEG9-OH Preparation Products And Raw materials |
|